GHK-Cu vs NAD+ — tissue vs energy.
Both ship in our Longevity Essentials bundle. Both get tagged "longevity research" in the marketing. They're barely in the same conversation though — GHK-Cu is a connective-tissue / skin-modulator working at the extracellular-matrix level, NAD+ is a cellular-energy co-enzyme working at the mitochondrial level. Different axes of ageing.
The short version.
GHK-Cuis a copper-binding tripeptide. It's researched primarily for wound-healing, collagen + elastin synthesis, hair-follicle activity, and connective-tissue repair. Strong topical literature, growing subcutaneous data.
NAD+ is the cellular currency of redox reactions. Every mitochondrion in every cell uses it. Researched for age-related decline in mitochondrial function, sirtuin-mediated longevity pathways, and DNA-repair-mediated cancer-prevention models.
They're complementary, not overlapping. Both research reference compounds — not for human consumption.
Side-by-side.
Which one fits your research?
Pick GHK-Cu alone if
- · Skin / scalp / hair-follicle research — strongest published data here.
- · Connective-tissue repair (tendon, ligament, scar tissue).
- · Topical-route protocols where dosing intermittency matters.
Pick NAD+ alone if
- · Mitochondrial / cellular-energy models · sirtuin pathway research.
- · Cognitive-decline / neurodegenerative research scope.
- · Long-cycle protocols (multi-month titration up).
Stack both (+ MOTS-c) if
- · Cross-axis longevity model: mitochondrial + connective-tissue + cellular energy.
- · The Longevity Essentials bundle adds MOTS-c (mitochondrial peptide) and saves ~10 %.
- · Research scope spans more than one ageing-related endpoint.
All compounds are research reference material — not for human consumption. Questions? Email the lab.